Skip to main content

Hospital-Acquired Disease Testing Market Remote Growing at High CAGR by 2027

Press release   •   Mar 01, 2019 12:06 IST

Hospital-Acquired Disease Testing Market to 2027

Hospital-Acquired Disease Testing Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

MARKET INTRODUCTION

Hospital acquired infections are caused due to viral, fungal and bacterial pathogens. A nosocomial infection also referred to as hospital-acquired infections occurs because of an infectious agent or toxin that exists in certain location of a medical facility. One of the most common wards where HAIs occur is the intensive care unit (ICU), where doctors treat serious diseases. Hospital-acquired diseases continue to be a major concern for healthcare industry.

Ask for a Sample of this Report Now at: http://bit.ly/2BZpKpZ

Hospital-Acquired Disease Testing Market to 2027 - Global Analysis and Forecasts By Test Type (UTI Tests, SSI Tests, Pneumococcal Infection Tests, Bloodstream Infection Tests, and MRSA Tests) End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Community Health Centers) and Geography

Key Benefits-

  • To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Hospital-Acquired Disease Testing Market
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

MARKET PLAYERS

Some of the key players influencing the market are Thermo Fisher Scientific Inc., Diatherix Eurofins, LLC, QIAGEN, Meridian Bioscience, Inc., Nordion (Canada) Inc., F. Hoffmann La Roche Ltd, Cantel Medical, Cepheid, Clinical Lab Products, and McKesson Medical-Surgical Inc. among others.

The Hospital-Acquired Disease Testing Market is anticipated to grow in the forecast period owing to driving factors such as developments in the technology for the medical devices, rise in the development for the healthcare infrastructure and rise in the investments for the automated healthcare facilities among the others. The market is likely to widen up opportunities for the market players to expand their business in the emerging regions.

MARKET SCOPE

The "Global Hospital-Acquired Disease Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global hospital-acquired disease testing market with detailed market segmentation by test type and end user. The global hospital-acquired disease testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Don’t miss out on business opportunities in Hospital-Acquired Disease Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

The global hospital-acquired disease testing market is segmented on the basis of test type and end user. On the basis of test type, the global hospital-acquired disease testing market is segmented into UTI tests, SSI tests, pneumococcal infection tests, bloodstream infection tests, and MRSA tests. Based on end user, the hospital-acquired disease testing market is segmented into hospitals, clinics, ambulatory surgical centers, and community health centers.

REGIONAL FRAMEWORK

North America dominated the hospital-acquired disease testing market in 2017, owing rising awareness among the patient population as well as developing healthcare infrastructure. Asia Pacific on the other hand is expected witness the highest growth over the forecast period in the hospital-acquired disease testing market owing to the availability of immense opportunities in countries like India, China & Japan. Sanitation problems in the healthcare facilities and increasing number of hospitals admissions are expected to be the driving factors for Asian growth.

The hospital-acquired disease testing market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Hospital-Acquired Disease Testing Market Segmentation

By Test Type

  • UTI tests
  • SSI tests
  • Pneumococcal infection tests
  • Bloodstream infection tests
  • MRSA tests

By End User

  • Hospitals
  • Clinics
  • Ambulatory surgical centers
  • Community health centers

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. HOSPITAL-ACQUIRED DISEASE TESTING MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Hospital-Acquired Disease Testing Market - By Test Type
3.2.2. Hospital-Acquired Disease Testing Market - By End User
3.2.3. Hospital-Acquired Disease Testing Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. HOSPITAL-ACQUIRED DISEASE TESTING MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. HOSPITAL-ACQUIRED DISEASE TESTING MARKET - GLOBAL ANALYSIS
5.1. GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
5.2. GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

Direct Purchase a Copy of this Report at: http://bit.ly/2VtiYjI

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.